ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

Prescriber Checkup » Oklahoma » Psychiatry

Top Psychiatry Prescribers in Oklahoma

Top Prescribers

Providers are grouped by the primary specialty they listed when applying for a national health ID number. This doesn’t necessarily mean the person has special training or certification. Specialty is self-reported by providers and may have changed. Patients and claims shown are for Medicare Part D only.

Prescriber Claims Filled Total Cost Medicare Part D Patients Claims for Brand Name Drugs Schedule Two Schedule Three Dangerous Drugs to Seniors Brand Name Drugs Prescription Price
JEFFREY SEAMAN MD

Psychiatry

949

$110K

60
30 are 65+

0%
patients receiving schedule two controlled substances

Avg: 3%

0%
patients receiving schedule three controlled substances

Avg: 1%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

24%
prescriptions for brand name drugs

Avg: 25%

$116
Average prescription price

Avg: $132

MICHAEL DUBRIWNY MD

Psychiatry

961

$121K

49
14 are 65+

0%
patients receiving schedule two controlled substances

Avg: 3%

0%
patients receiving schedule three controlled substances

Avg: 1%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

27%
prescriptions for brand name drugs

Avg: 25%

$126
Average prescription price

Avg: $132

WALLACE HELLER MD

Psychiatry

1,021

$166K

83
14 are 65+

0%
patients receiving schedule two controlled substances

Avg: 3%

0%
patients receiving schedule three controlled substances

Avg: 1%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

33%
prescriptions for brand name drugs

Avg: 25%

$163
Average prescription price

Avg: $132

ELIZABETH FOOTE M.D.

Psychiatry

1,035

$151K

68
0 are 65+

0%
patients receiving schedule two controlled substances

Avg: 3%

21%
patients receiving schedule three controlled substances

Avg: 1%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

28%
prescriptions for brand name drugs

Avg: 25%

$146
Average prescription price

Avg: $132

MARY-ANNE KOWOL M.D.

Psychiatry

1,041

$148K

74
24 are 65+

0%
patients receiving schedule two controlled substances

Avg: 3%

0%
patients receiving schedule three controlled substances

Avg: 1%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

26%
prescriptions for brand name drugs

Avg: 25%

$143
Average prescription price

Avg: $132

AMAL CHAKRABURTTY MD

Psychiatry

1,044

$139K

138
43 are 65+

0%
patients receiving schedule two controlled substances

Avg: 3%

0%
patients receiving schedule three controlled substances

Avg: 1%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

31%
prescriptions for brand name drugs

Avg: 25%

$133
Average prescription price

Avg: $132

JEAN HELMBRIGHT MD

Psychiatry

1,053

$237K

29
0 are 65+

0%
patients receiving schedule two controlled substances

Avg: 3%

0%
patients receiving schedule three controlled substances

Avg: 1%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

26%
prescriptions for brand name drugs

Avg: 25%

$226
Average prescription price

Avg: $132

JOE SPEER M.D.

Psychiatry

1,091

$157K

77
0 are 65+

0%
patients receiving schedule two controlled substances

Avg: 3%

0%
patients receiving schedule three controlled substances

Avg: 1%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

22%
prescriptions for brand name drugs

Avg: 25%

$143
Average prescription price

Avg: $132

NARAYANA PAI M.D.

Psychiatry

1,130

$92K

90
63 are 65+

0%
patients receiving schedule two controlled substances

Avg: 3%

0%
patients receiving schedule three controlled substances

Avg: 1%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

30%
prescriptions for brand name drugs

Avg: 25%

$81
Average prescription price

Avg: $132

ANTON SURJA MD

Psychiatry

1,144

$131K

104
29 are 65+

0%
patients receiving schedule two controlled substances

Avg: 3%

0%
patients receiving schedule three controlled substances

Avg: 1%

4%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

24%
prescriptions for brand name drugs

Avg: 25%

$115
Average prescription price

Avg: $132

JOHN WHITE MD

Psychiatry

1,159

$126K

143
62 are 65+

0%
patients receiving schedule two controlled substances

Avg: 3%

0%
patients receiving schedule three controlled substances

Avg: 1%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

19%
prescriptions for brand name drugs

Avg: 25%

$109
Average prescription price

Avg: $132

MARK GAGE DO

Psychiatry

1,197

$162K

191
13 are 65+

0%
patients receiving schedule two controlled substances

Avg: 3%

0%
patients receiving schedule three controlled substances

Avg: 1%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

28%
prescriptions for brand name drugs

Avg: 25%

$136
Average prescription price

Avg: $132

PARIND SHAH MD

Psychiatry

1,213

$175K

278
28 are 65+

0%
patients receiving schedule two controlled substances

Avg: 3%

0%
patients receiving schedule three controlled substances

Avg: 1%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

26%
prescriptions for brand name drugs

Avg: 25%

$144
Average prescription price

Avg: $132

MATTHEW MEYER MD

Psychiatry

1,277

$250K

86
20 are 65+

14%
patients receiving schedule two controlled substances

Avg: 3%

0%
patients receiving schedule three controlled substances

Avg: 1%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

23%
prescriptions for brand name drugs

Avg: 25%

$196
Average prescription price

Avg: $132

THERESA GARTON MD

Psychiatry

1,330

$214K

86
17 are 65+

0%
patients receiving schedule two controlled substances

Avg: 3%

0%
patients receiving schedule three controlled substances

Avg: 1%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

26%
prescriptions for brand name drugs

Avg: 25%

$161
Average prescription price

Avg: $132

SAMUEL LENSGRAF MD

Psychiatry

1,337

$173K

100
63 are 65+

0%
patients receiving schedule two controlled substances

Avg: 3%

0%
patients receiving schedule three controlled substances

Avg: 1%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

28%
prescriptions for brand name drugs

Avg: 25%

$130
Average prescription price

Avg: $132

EDWIN HILL MD

Psychiatry

1,357

$210K

111
13 are 65+

0%
patients receiving schedule two controlled substances

Avg: 3%

0%
patients receiving schedule three controlled substances

Avg: 1%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

22%
prescriptions for brand name drugs

Avg: 25%

$155
Average prescription price

Avg: $132

JAMES PLETCHER DO

Psychiatry

1,360

$128K

155
49 are 65+

0%
patients receiving schedule two controlled substances

Avg: 3%

0%
patients receiving schedule three controlled substances

Avg: 1%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

26%
prescriptions for brand name drugs

Avg: 25%

$94
Average prescription price

Avg: $132

WILLIAM HAMILTON M.D.

Psychiatry

1,397

$135K

130
91 are 65+

0%
patients receiving schedule two controlled substances

Avg: 3%

0%
patients receiving schedule three controlled substances

Avg: 1%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

25%
prescriptions for brand name drugs

Avg: 25%

$97
Average prescription price

Avg: $132

JOHN RAHHAL MD

Psychiatry

1,408

$165K

120
44 are 65+

13%
patients receiving schedule two controlled substances

Avg: 3%

0%
patients receiving schedule three controlled substances

Avg: 1%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

26%
prescriptions for brand name drugs

Avg: 25%

$118
Average prescription price

Avg: $132

DAVID MITCHELL MD

Psychiatry

1,440

$201K

157
11 are 65+

0%
patients receiving schedule two controlled substances

Avg: 3%

0%
patients receiving schedule three controlled substances

Avg: 1%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

25%
prescriptions for brand name drugs

Avg: 25%

$139
Average prescription price

Avg: $132

MARYELLEN DODD M.D.

Psychiatry

1,440

$167K

107
32 are 65+

17%
patients receiving schedule two controlled substances

Avg: 3%

0%
patients receiving schedule three controlled substances

Avg: 1%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

24%
prescriptions for brand name drugs

Avg: 25%

$116
Average prescription price

Avg: $132

DOMINIC LOSACCO MD

Psychiatry

1,464

$236K

115
83 are 65+

22%
patients receiving schedule two controlled substances

Avg: 3%

0%
patients receiving schedule three controlled substances

Avg: 1%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

43%
prescriptions for brand name drugs

Avg: 25%

$161
Average prescription price

Avg: $132

MARK MEDLIN M.D.

Psychiatry

1,527

$246K

182
44 are 65+

0%
patients receiving schedule two controlled substances

Avg: 3%

0%
patients receiving schedule three controlled substances

Avg: 1%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

28%
prescriptions for brand name drugs

Avg: 25%

$161
Average prescription price

Avg: $132

SATWANT TANDON MD

Psychiatry

1,555

$199K

102
19 are 65+

0%
patients receiving schedule two controlled substances

Avg: 3%

0%
patients receiving schedule three controlled substances

Avg: 1%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

22%
prescriptions for brand name drugs

Avg: 25%

$128
Average prescription price

Avg: $132

Sources

Centers for Medicare and Medicaid Services; National Technical Information Service; First Databank